Cargando…

Neoadjuvant chemoradiation changes podoplanin expression in esophageal cancer patients

BACKGROUND: Locally advanced adenocarcinoma of the esophagus (EAC) and squamous cell carcinoma (ESCC) result in a worse prognosis. Neoadjuvant treatment improves survival, however, only for responders. The transmembrane glycoprotein podoplanin is overexpressed in squamous cell carcinomas, miRNA-363...

Descripción completa

Detalles Bibliográficos
Autores principales:	Warnecke-Eberz, Ute, Plum, Patrick, Schweinsberg, Viola, Drebber, Uta, Bruns, Christiane J, Müller, Dolores T, Hölscher, Arnulf H, Bollschweiler, Elfriede
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Basic Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336324/ https://www.ncbi.nlm.nih.gov/pubmed/32684738 http://dx.doi.org/10.3748/wjg.v26.i23.3236

Ejemplares similares

Upregulation of miR-17-92 cluster is associated with progression and lymph node metastasis in oesophageal adenocarcinoma
por: Plum, Patrick Sven, et al.
Publicado: (2019)

External Validation of Pretreatment Pathological Tumor Extent in Patients with Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer
por: Brinkmann, Sebastian, et al.
Publicado: (2019)

Duodeno-Gastric-Esophageal Reflux—What is Pathologic? Comparison of Patients with Barrett’s Esophagus and Age-Matched Volunteers
por: Wolfgarten, Eva, et al.
Publicado: (2007)

Effect of aging on esophageal motility in patients with and without GERD
por: Gutschow, Christian A., et al.
Publicado: (2011)

Evaluation of POSSUM scoring system in patients with gastric cancer undergoing D2-gastrectomy
por: Bollschweiler, Elfriede, et al.
Publicado: (2005)

Short-term outcome of Ivor Lewis esophagectomy following neoadjuvant chemoradiation versus perioperative chemotherapy in patients with locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: a propensity score-matched analysis
por: Plum, Patrick Sven, et al.
Publicado: (2021)

Long-Term Postsurgical Outcomes of Neoadjuvant Chemoradiation (CROSS) Versus Chemotherapy (FLOT) for Multimodal Treatment of Adenocarcinoma of the Esophagus and the Esophagogastric Junction
por: Gebauer, Florian, et al.
Publicado: (2023)

High protein and mRNA expression levels of TUBB3 (class III ß-tubulin) are associated with aggressive tumor features in esophageal adenocarcinomas
por: Loeser, Heike, et al.
Publicado: (2017)

Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma
por: Matani, Hirsch, et al.
Publicado: (2022)

Somatic alterations in circulating cell-free DNA of oesophageal carcinoma patients during primary staging are indicative for post-surgical tumour recurrence
por: Pasternack, Helen, et al.
Publicado: (2018)

Multidisciplinary treatment of esophageal cancer: The role of active surveillance after neoadjuvant chemoradiation
por: Triantafyllou, Tania, et al.
Publicado: (2020)

Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer
por: Miyazono, F, et al.
Publicado: (2004)

Development of Hepatocellular Carcinoma Associated with Anabolic Androgenic Steroid Abuse in a Young Bodybuilder: A Case Report
por: Hardt, Aline, et al.
Publicado: (2012)

Handgrip Strength Is Associated With Treatment Modifications During Neoadjuvant Chemoradiation in Patients With Esophageal Cancer
por: Lakenman, Patty, et al.
Publicado: (2017)

Lymphopenia and Radiation Dose to Circulating Lymphocytes With Neoadjuvant Chemoradiation in Esophageal Squamous Cell Carcinoma
por: So, Tsz Him, et al.
Publicado: (2020)

DNA methylation biomarkers accurately detect esophageal cancer prior and post neoadjuvant chemoradiation
por: Macedo‐Silva, Catarina, et al.
Publicado: (2023)

HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma
por: Plum, Patrick Sven, et al.
Publicado: (2019)

Prognostic relevance of demographics and surgical practice for patients with gastric cancer in two centers: in Poland versus Germany
por: Jaworski, Radoslaw, et al.
Publicado: (2011)

Clinical significance of risk stratification of esophageal squamous cell carcinoma after neoadjuvant chemoradiation and surgery
por: Wu, Ya-hua, et al.
Publicado: (2021)

Bayesian analysis supports the role of neoadjuvant chemoradiation followed by surgery for resectable locoregional esophageal cancer
por: Rizzo, Alessandro
Publicado: (2022)

Estrogen-related receptor alpha drives mitochondrial biogenesis and resistance to neoadjuvant chemoradiation in esophageal cancer
por: Dings, Mark P.G., et al.
Publicado: (2022)

Prognostic significance of tumor regression grade in esophageal squamous cell carcinoma after neoadjuvant chemoradiation
por: Zhang, Chi, et al.
Publicado: (2023)

Tumor Microenvironment of Esophageal Cancer
por: Schiffmann, Lars M., et al.
Publicado: (2021)

GATA binding protein 6 (GATA6) is co-amplified with PIK3CA in patients with esophageal adenocarcinoma and is linked to neoadjuvant therapy
por: Plum, Patrick Sven, et al.
Publicado: (2020)

Expression of podoplanin and vimentin is correlated with prognosis in esophageal squamous cell carcinoma
por: TANAKA, MAKIKO, et al.
Publicado: (2015)

Lymph Node Status after Neoadjuvant Chemoradiation Therapy for Esophageal Cancer according to Radiation Field Coverage
por: Kim, Sang Yoon, et al.
Publicado: (2019)

Prognostic significance of lymph node ratio after neoadjuvant chemoradiation therapy for esophageal squamous cell carcinoma
por: Jang, Jeong Yun, et al.
Publicado: (2020)

Residual lymph node disease and mortality following neoadjuvant chemoradiation and curative esophagectomy for distal esophageal adenocarcinoma
por: Kandilis, Apostolos, et al.
Publicado: (2020)

Trimodal Therapy in Esophageal Squamous Cell Carcinoma: Role of Adjuvant Therapy Following Neoadjuvant Chemoradiation and Surgery
por: Li, Xiaokun, et al.
Publicado: (2022)

Reply: Bayesian analysis supports the role of neoadjuvant chemoradiation followed by surgery for resectable locoregional esophageal cancer
por: Bao, Yongxing, et al.
Publicado: (2022)

Comparison of outcomes between neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy in patients with locally advanced esophageal cancer: A network meta-analysis
por: Fan, Ningbo, et al.
Publicado: (2021)

New approaches in esophageal carcinomas
por: Hölscher, Arnulf H., et al.
Publicado: (2016)

Response Evaluation after Neoadjuvant Chemoradiation by Positron Emission Tomography-Computed Tomography for Esophageal Squamous Cell Carcinoma
por: Park, Joon Suk, et al.
Publicado: (2013)

Radiation dose does not influence anastomotic complications in patients with esophageal cancer treated with neoadjuvant chemoradiation and transhiatal esophagectomy
por: Koëter, Marijn, et al.
Publicado: (2015)

A Prospective Study of Early Radiation Associated Cardiac Toxicity Following Neoadjuvant Chemoradiation for Distal Esophageal Cancer
por: Burke, Aidan M., et al.
Publicado: (2020)

Comment on “bronchus perforation by EZ-Blocker(TM) endobronchial blocker during esophageal resection after neoadjuvant chemoradiation”
por: Parab, Swapnil Y
Publicado: (2019)

Short- and long-term follow-up of patients with non-neoplastic esophageal perforation
por: Brinkmann, Sebastian, et al.
Publicado: (2021)

Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer
por: Habermehl, Daniel, et al.
Publicado: (2012)

Neoadjuvant Chemoradiation Herapy for Soft Tissue Sarcomas of the Extremities
por: Aguiar, Samuel, et al.
Publicado: (2009)

Scrotal and Penile Erythrodysesthesia Associated with Neoadjuvant Capecitabine Chemoradiation
por: Dricken, Julie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7u6gfv11t630sn99n9jcvo9jee